The Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China
NCT Number: NCT06535217
Clinically, organ evaluation generally performed by the senior surgeons based on their experience and the visual and tactual inspection of the graft during procurement. However, it is proved that transplant surgeons intuition in the evaluation of donor risk and the estimation of steatosis is inconsistent and usually inaccurate. Besides, graft assessment is a dynamic process refer to amount of complex factors, which is considered to be an incredibly complicated relationship that is nonlinear in nature. Unfortunately, the classical statistic techniques in vogue such as multiple regression require the statistical assumption of independent and linear relationships between explanatory and outcome variables, and fail to analyse a large number of variables. We attempted to develop liver graft assessment models by predicting postoperative DGF using several ML techniques. Secondly, the best prediction model was selected by comparing the performance of different AI algorithms and logistic regression. Finally, we sought to explain the decision made by AI algorithms using a visualization algorithm based on the best prediction model, helping clinicians evaluate specific organ and whether to receive that may develop DGF postoperatively.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Guangzhou, Guangdong, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Liver transplantation
Time frame: Within 7 days after liver transplantation
defined as early graft dysfunction without the need for a second liver transplant or death
Third Affiliated Hospital, Sun Yat-Sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05818644
Hematologic Diseases, Hemic and Lymphatic Diseases
Groningen, Netherlands
View Trial DetailsNCT05042505
Diabetes Mellitus, Endocrine System Diseases
Gurgaon, Haryana, India
View Trial DetailsNCT06879106
Behavior, Compliance, Treatment
Bitlis, Turkey (Türkiye)
View Trial DetailsNCT07362745
Digestive System Diseases, End Stage Liver Disease
Xi'an, Shaanxi, China
View Trial Details